Orasure Technologies Inc.

NASDAQ:OSUR  
9.64
-0.01 (-0.10%)
Products

Orasure Technologies - FDA Requested Additional Analytical Data For EUA Application For Use Of Orasure SARS Cov-2 Antibody Elisa

Published: 05/26/2021 12:06 GMT
Orasure Technologies Inc. (OSUR) - Orasure Technologies - FDA Requested Additional Analytical Data for Eua Application for Use of Orasure Sars Cov-2 Antibody Elisa.
Orasure Technologies - FDA Requested Co Provide Additional Data on Sample Collection, Stability.
Orasure Technologies - FDA Requested Co Resubmit Separate Euas for Antibody Elisa and Orasure Oral Antibody Collection Device.
Orasure Technologies - on May 21, Submitted Applications for Separate Euas As Requested by the FDA.